Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Anavex Life Sciences Corp. (AVXL) had Normalized Income after Taxes of $-8.62M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-8.62M |
|
-- |
|
-- |
|
$11.29M |
|
$-11.29M |
|
$2.76M |
|
$-8.54M |
|
$-8.54M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
|
Normalized Income after Taxes |
$-8.62M |
$-11.29M |
|
$-11.29M |
|
82.08M |
|
82.08M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$148.07M |
|
-- |
|
-- |
|
$148.07M |
|
$12.49M |
|
-- |
|
-- |
|
$12.49M |
|
$135.57M |
|
$135.57M |
|
$135.57M |
|
82.09M |
|
| Cash Flow Statement Financials | |
$-7.32M |
|
-- |
|
$0.06M |
|
$151.02M |
|
$143.76M |
|
$-7.26M |
|
$2.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.36% |
|
-6.36% |
|
-5.82% |
|
-6.36% |
|
$1.65 |
|
$-0.09 |
|
$-0.09 |
|